EVNIN LUKE sold 10.2% of their position (291.28K shares) of WEREWOLF THERAPEUTICS, INC. on the open market
Open‑market sale worth $185.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 5 sales
Filed: 12/29/2025ACC: 0001134657-25-000018
Director10% Owner
Since Apr 2021
-291.28K
Net shares
Net seller
$185.2K
Total sold
5
Open market trades
0B · 5S
5
Total transactions
291.28K disposed
Non-Derivative Transactions5
Common Stock
Indirect
Shares
−59.31K
Price / share
$0.69
Trade value
$40.92K
% of position
2.1%
12/22/2025
2.84M→2.78M
Common Stock
Indirect
Shares
−71.43K
Price / share
$0.63
Trade value
$45K
% of position
2.6%
12/23/2025
2.78M→2.71M
Common Stock
Indirect
Shares
−16.31K
Price / share
$0.65
Trade value
$10.60K
% of position
0.6%
12/24/2025
2.71M→2.69M
Common Stock
Indirect
Shares
−35.63K
Price / share
$0.63
Trade value
$22.45K
% of position
1.3%
12/26/2025
2.69M→2.66M
Common Stock
Indirect
Shares
−108.61K
Price / share
$0.61
Trade value
$66.25K
% of position
4.1%
12/29/2025
2.66M→2.55M
Total
Net shares
−291.28K
Net value
-$185.22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/22/2025 | S · Sale | −59.31K | $0.69 | $40.92K | 2.1% | 2.84M | 2.78M |
| Common Stock Indirect | 12/23/2025 | S · Sale | −71.43K | $0.63 | $45K | 2.6% | 2.78M | 2.71M |
| Common Stock Indirect | 12/24/2025 | S · Sale | −16.31K | $0.65 | $10.60K | 0.6% | 2.71M | 2.69M |
| Common Stock Indirect | 12/26/2025 | S · Sale | −35.63K | $0.63 | $22.45K | 1.3% | 2.69M | 2.66M |
| Common Stock Indirect | 12/29/2025 | S · Sale | −108.61K | $0.61 | $66.25K | 4.1% | 2.66M | 2.55M |
| Total | −291.28K | -$185.22K | ||||||
Derivative Transactions0
No derivative transactions reported